# Clinical Trials Market Insights by Leading Companies and Emerging Growth till 2030
Author:  Pal Sinha, Barnali 
Author URL: https://financedigest.com/author/pal-sinha-barnali
Published: 2021-12-01
Category: Research Reports
Category URL: https://financedigest.com/category/research-reports
Meta Title: Global Clinical Trials Market: Driving Factors & Growth
Meta Description: Discover the latest market insights on the global clinical trials market, with projections showing high growth potential driven by R&D activities and rising
URL: https://financedigest.com/clinical-trials-market-insights-by-leading-companies-and-emerging-growth-till-2030html

![undefined](https://prod.superblogcdn.com/site_cuid_cm5qst7v3003gwirgwqtxn8i8/images/research-report-2-1736836779474-compressed.jpg)

**Clinical trials Market: Introduction**

According to the report, the global [clinical trials market](https://www.transparencymarketresearch.com/clinical-trials-market.html) was valued over US$ 46.7 Bn in 2019 and is projected to expand at a CAGR of ~5% from 2020 to 2030. High prevalence and increase in incidence rate of chronic diseases, and rise in R&D activities in biotechnology & pharmaceuticals industries are anticipated to drive the global [clinical trials market](https://www.financedigest.com/the-clinical-nutrition-market-to-escalate-on-a-holistic-note.html "The Clinical Nutrition Market To Escalate On A Holistic Note") from 2020 to 2030. North America is projected to be a highly attractive market during the forecast period. The region is anticipated to account for the largest share of the [global market](https://www.financedigest.com/global-precision-components-and-tooling-systems-market-assessment-and-key-insights-analyzed-till-2027.html "Global Precision Components And Tooling Systems Market Assessment and Key Insights Analyzed Till 2027") by 2030. The [market in the region is expected](https://www.financedigest.com/silver-cyanide-market-expectations-growth-trends-highlighted-until-2028.html "Silver Cyanide Market Expectations & Growth Trends Highlighted Until 2028") to grow at a rapid pace from 2020 to 2030. [Increase in R&D and rise in adoption of new technologies](https://www.financedigest.com/lumen-registers-increased-views-and-more-positive-response-to-ads-using-seenthis-technology.html "Lumen registers increased views and more positive response to Ads using SeenThis Technology") in clinical research are likely to propel the market in North America. The incorporation of virtual services in the [clinical trial protocol by market](https://www.financedigest.com/lactoferrin-market-to-exceed-us-711-9-million-by-2033-amid-rising-applications-in-clinical-nutrition-and-infant-formulas-future-market-insights-inc.html "Lactoferrin Market to Exceed US$ 711.9 Million by 2033 Amid Rising Applications in Clinical Nutrition and Infant Formulas | Future Market Insights Inc. ") players such as IQVIA and PRA Health Sciences is projected to boost the market in North America.

Europe is [anticipated to be the second most attractive market](https://www.financedigest.com/turpentine-market-anticipated-to-exceed-us-1-51-bn-by-2028-fmi.html "Turpentine Market anticipated to exceed US$ 1.51 Bn by 2028 – FMI") for clinical trials during the forecast period. Support from the government for activities such as research & development for new treatment procedures and upcoming infectious diseases, along with chronic diseases are expected to drive the clinical trials market in Europe during the forecast period.

**Request for Report Brochure –** [https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep\_id=78053](https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=78053)

The [market in Asia Pacific is expected to expand at the highest CAGR](https://www.financedigest.com/bag-in-tube-market-estimated-to-expand-at-a-robust-cagr-by-2029.html "Bag-in-Tube Market Estimated to Expand at a Robust CAGR By 2029") from 2020 to 2030. Increase in the number of clinical trials and biotechnology firms in Asia Pacific is projected to drive the clinical trials market in the region over the [next few years](https://www.financedigest.com/start-up-etioca-eyes-nasdaq-listing-next-year-as-it-unveils-electric-taxi.html "Start-up Etioca eyes Nasdaq listing next year as it unveils electric taxi").

**High Prevalence and [Increase in Incidence Rate](https://www.financedigest.com/how-to-increase-repeat-purchase-rates-in-ecommerce.html "How to increase repeat purchase rates in eCommerce") of Chronic Diseases to Drive Market**

Chronic diseases such as chronic respiratory diseases (CRD), diabetes, chronic kidney diseases (CKD), cancer, cardiac stroke, and neurological disorders are the leading causes of disability and mortality across the globe. The [emergence and outbreak of various infectious and chronic diseases have created challenges and new opportunities](https://www.financedigest.com/digital-payments-an-explosion-of-emerging-opportunities.html "Digital Payments: An Explosion of Emerging Opportunities") for researchers to develop new diagnostic tools, tests, drugs, and vaccines for early diagnosis, prevention, and cure of such diseases. Hepatitis and HIV are the other major infectious diseases. According to the [World Health Organization](https://www.financedigest.com/explainer-how-the-world-health-organization-might-fight-future-pandemics.html "Explainer-How the World Health Organization might fight future pandemics") (WHO), as of October 2017, around 71 million people across the world were estimated to have hepatitis C infection. The WHO also stated that 36.7 million people were affected with HIV across the globe. These factors contribute to the [growth of the global](https://www.financedigest.com/kelda-technology-pushes-ahead-with-global-growth-plans-afternew-appointment.html "Kelda Technology pushes ahead with global growth plans afternew appointment") clinical trials market.

[**Rise in R&D Activities in Biotechnology and Pharmaceuticals Industries Propels Global Market**](https://www.financedigest.com/ott-content-market-to-rise-to-a-valuation-of-us-245814-4-mn.html "OTT Content Market to rise to a valuation of US$ 245,814.4 Mn")

Clinical research organizations, diagnostic laboratories, and biotechnology players are engaged in the development of newer diagnostic tests to address the unmet [needs in the healthcare industry](https://www.financedigest.com/the-financial-services-industry-needs-to-get-serious-about-cyber-security-in-the-covid-19-era.html "The financial services industry needs to get serious about cyber security in the Covid-19 era"). The life science industry’s R&D spending is driven primarily by the mass and research intensity of the biopharmaceutical sector, which accounts for nearly 85% of all expenditures. The acceleration in biopharmaceutical R&D innovation, buoyed by several contributing factors such as precision medicine getting into gear in rare diseases, cancer, and autoimmune diseases; immunotherapy, expansion of therapeutic modalities exploiting natural and synthetic biology innovation, and expedited regulatory pathways [boost the growth](https://www.financedigest.com/uk-businesses-call-for-looser-immigration-rules-to-boost-growth.html "UK businesses call for looser immigration rules to boost growth") of the clinical trials market.

**Request for Analysis of COVID-19 Impact on Clinical Trials Market –** [https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep\_id=78053](https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=78053)

**Phase III to Dominate Market**

In terms of phase, the global clinical trials market has been divided into phase I, phase II, phase III, and phase IV. The phase III segment held major [market share in 2019 and the trend is projected to continue during the forecast](https://www.financedigest.com/semillon-market-covid-19-effect-trends-together-with-growth-forecast-to-2030.html "Semillon Market (Covid-19) Effect: Trends Together With Growth Forecast To 2030") period. The segment is anticipated to register the highest market attractiveness during the forecast period.

**Oncology to be Major Indication**

Based on indication, the global clinical trials market has been classified into autoimmune/inflammation, pain management, cardiovascular, CNS condition, oncology, diabetes, obesity, and others. The oncology segment accounted for major [share of 23.5% of the global clinical trials market](https://www.financedigest.com/world-shares-rally-as-china-offers-markets-a-hand.html "World shares rally as China offers markets a hand") in 2019. The oncology segment is anticipated to create incremental opportunity of US$ 8,758.5 Mn during the forecast period. The segment is projected to capture 24.4% market share by 2030. The segment is expected to [expand at a high CAGR](https://www.financedigest.com/triple-offset-butterfly-valves-market-to-expand-at-over-4-cagr-through-2031.html "Triple Offset Butterfly Valves market to expand at over 4 % CAGR through 2031") of 5.8% from 2020 to 2030. The growth of the segment can be attributed to increase in the number of clinical trials in the oncology segment.

**Buy Clinical Trials Market Report –** [https://www.transparencymarketresearch.com/checkout.php?rep\_id=78053&ltype=S](https://www.transparencymarketresearch.com/checkout.php?rep_id=78053&ltype=S)

**Competition Landscape in Clinical Trials Market**

The report provides profiles of [leading players operating in the global clinical trials market](https://www.financedigest.com/lead-market-to-grow-at-a-rate-of-5-from-2022-to-2032-owing-to-the-growing-demand-for-lead-acid-batteries-globally-future-market-insights-inc.html "Lead Market to grow at a rate of 5% from 2022 to 2032 Owing to the Growing Demand for Lead-Acid Batteries Globally | Future Market Insights, Inc."). These include Laboratory Corporation of America Holdings, IQVIA, Inc., Syneos Health, Parexel International Corporation, PRA Health Sciences, Inc., PPD, Inc., Icon plc, Charles River Laboratories, Inc., WuXi AppTec, and Medpace Holdings, Inc.

**About Us**

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to [business leaders](https://www.financedigest.com/how-leaders-can-develop-their-business-intuition.html "How Leaders Can Develop Their Business Intuition"), consultants, and strategy professionals. Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time [data collection methods along with ability to track more than one million high growth](https://www.financedigest.com/bridge-the-gaps-in-big-data-and-cross-into-a-world-of-growth.html "Bridge the gaps in Big Data – and cross into a world of growth") niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information, we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

**Contact Us**

Mr. Rohit Bhisey

Transparency Market Research

USA – Canada Toll Free: 866-552-3453

**Email:** [sales@transparencymarketresearch.com](mailto:sales@transparencymarketresearch.com)

**Blog:** [https://tmrblog.com/](https://tmrblog.com/)

**Follow Us**: [Twitter](https://twitter.com/research_market) **\|** LinkedIn

**Press Release Source:** [**https://www.transparencymarketresearch.com/pressrelease/clinical-trials-market.htm**](https://www.transparencymarketresearch.com/pressrelease/clinical-trials-market.htm)


---
This blog is powered by Superblog. Visit https://superblog.ai to know more.
---